Together we will beat cancerDonate
New results find that the HPV vaccine was shown to dramatically reduce cervical cancer rates by 90% in women in their 20s who were offered it at age 12 to 13.
It’s completely up to you whether to go to cervical cancer screening. But the answers to these 6 questions could help you decide.
The spin out companies are engineering viruses to seek and destroy cancer cells and using bacteria to break down the physical defences of tumours.
We want to have a conversation about human papillomavirus (HPV), starting with 6 questions about HPV people frequently ask our Cancer Research UK nurses.
Last year, the World Health Organisation (WHO) announced their plans to create a global strategy to accelerate the elimination of cervical cancer as a public health problem.
Long awaited study results have confirmed that the quadrivalent human papillomavirus (HPV) vaccine substantially reduces invasive cervical cancer risk.
Cervical cancer rates are predicted to fall following the introduction of HPV primary screening this year.
The Joint Committee for Vaccination and Immunisation has recommended that boys are offered the HPV vaccine. We look at what this could mean and next steps.
Following our research on how lifestyle affects cancer risk, we look at how research into vaccines, screening and drugs could also help prevent cancers.
New research shows women who have had the HPV vaccine may only need 3 cervical screens in their entire life, rather than the 12 that are standard in the UK.